Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| EXTRA STRENGTH TYLENOL DAYTIME RELIEF | mcneil consumer healthcare division of johnson & johnson inc | Marketed | Jun 7, 2024 | Marketed |
| NRA-BETAHISTINE | nora pharma inc | Marketed | Jun 5, 2024 | Marketed |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | baxter corporation | Marketed | Jun 5, 2024 | Marketed |
| NRA-BETAHISTINE | nora pharma inc | Marketed | Jun 5, 2024 | Marketed |
| NRA-BETAHISTINE | nora pharma inc | Marketed | Jun 5, 2024 | Marketed |
| M-DOXYCYCLINE | mantra pharma inc | Marketed | Jun 5, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
| FAVE FLUID SPF50+ ULTRALIGHT SCREEN | GRACE & FIRE PTY LTD | Marketed | Jun 4, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
| HYOSCINE BUTYLBROMIDE INJECTION BP | omega laboratories limited | Marketed | Jun 4, 2024 | Marketed |
| METOCLOPRAMIDE HYDROCHLORIDE INJECTION | baxter corporation | Marketed | Jun 4, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Jun 4, 2024 | Marketed |
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
